Euro India Fresh (EIFFL)
StalwartFairStock Score: 21/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹274.7 |
| Market Cap | ₹681.26 Cr |
| P/E Ratio | 136.67 |
| ROCE | 9.9% |
| ROE | 6.65% |
| Dividend Yield | 0% |
| Profit Growth | 80.5% |
| Debt/Equity | 0.77 |
| Sales Growth | 71.6% |
| Promoter Holding | 73.5% |
| 52-Week Range | ₹204.98 — ₹381.96 |
| Sector | Food Products |
| Book Value | ₹30.99 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
When I first glance at Euro India Fresh, the numbers shout caution. Sales are down 40.6% and profits down 48.57%. A healthy business does not shrink by two-fifths in a year. The latest quarter confirms the erosion: just ₹28 crore in sales and ₹1 crore net profit. At a market cap of ₹578 crore, I am paying 198 times trailing earnings for a company that is visibly contracting. Benjamin Graham taught me that price is what you pay, value is what you get. Here, I get a book value of ₹29.12 per share, so the market price of ₹247.97 is about 8.5 times book. That premium could only be justified by exceptional profitability and growth, but ROCE is only 9.9% and return on equity is not even reported—likely weak or negative. The Piotroski F-score of 3/9 indicates poor financial health. Debt-to-equity of 0.85 is not catastrophic, but with falling revenue, debt service can become burdensome. There is no dividend yield; I earn nothing while waiting. The promoter holding at 73.5% is high, which is sometimes positive, but it does not compensate for deteriorating fundamentals. Is there a moat? In packaged foods, a moat comes from brand loyalty, distribution scale, or cost advantage. I see no evidence of that from these figures—instead, I see a business losing traction. This looks like a value trap rather than an opportunity. A distressed or turnaround situation requires a margin of safety and a clear path back to growth. I find neither here. At this price, the downside seems far larger than the upside. I will wait on the sidelines until the company can demonstrate consistent recovery, stabilize sales, and earn a return on capital that justifies its valuation. For now, this is a pass.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer